HSV1-tk肺腺癌报告基因显像与自杀基因治疗的研究基础
|
摘要
目的
现今肺癌的发病率和死亡率增长迅速,已成为人类死亡的主要原因之一,各细胞类型中以肺腺癌的增加尤为明显。临床发现多为中晚期,手术及放化疗的总体疗效不甚乐观,易出现局部复发及远处转移。基因治疗是目前肺癌治疗的研究热点之一,其中自杀基因(suicidegene)治疗被认为是最有应用前景的基因治疗方法。
目前,诸多治疗基因中单纯疱疹病毒胸苷激酶HSV1-tk基因研究最多,是最具前景的具有催化放射性核素的“自杀基因”。此外,HSV1-tk还兼具报告基因功能,故建立携带tk基因的肺腺癌裸鼠动物模型后,可在活体状态下能表达胸苷激酶ΓK。18F、124I、131I等标记的核苷类似物作为底物进行反应后通过PET显像实时监测HSV1-tk自杀基因在靶细胞内的表达情况,为今后进一步深入研究肺癌的自杀基因治疗研究和监测奠定基础。同时,也可以为下一步进行双报告基因报告显像跟踪监测骨髓间充质干细胞的活体修复等工作奠定可行性基础。
内容
将外源自杀基因特异地导入肿瘤细胞内并在靶细胞内高效且稳定的表达是能否成功基因治疗肿瘤的关键。对患者体内的自杀基因分布转导情况和治疗状态进行实时检测分析也是整个治疗过程中不可或缺的部分。故本研究拟在前期研究的基础上利用逆转录病毒载体介导HSV1-tk自杀基因兼报告基因转染肺腺癌A549细胞,经筛选阳性转导细胞,再利用稀释法单克隆建立一种能稳定表达HSV1-tk基因肺腺癌细胞株A549-tk,观察其与正常A549细胞的形态和生长状态的区别。建立能在活体内长期、稳定、高效表达HSV1-tk基因的肺腺癌裸鼠动物模型。
方法
利用分子克隆技术扩增带Bg1II、Sa1I酶切位点的HSV1-tk全基因片段,插入逆转录病毒载体pDON-AI-2-Neo中,与gag-pol表达质粒pGP和env表达质粒pE-ampho利用脂质体法转染293T包装细胞,形成pDON-AI-2-Neo-HSVI-tk重组报告基因假病毒颗粒,然后用其转染肺癌A549细胞,经G418筛选阳性表达,再经有限稀释法单克隆获得稳定表达株,RT-PCR检测证实A549-tk细胞的外源HSV1-tk基因在mRNA水平的稳定表达。通过长时间的传代培养进行细胞的生长、形态观察并绘制细胞生长曲线。将克隆细胞株种瘤于裸鼠后,比较正常A549瘤和A549-tk瘤两者之间的生长差异,取动物模型的成瘤做RT-PCR检测到HSV1-tk基因的表达.
结果
重组质粒pDON-AI-2-Neo-HSV1-tk经过酶切、测序鉴定证明与GenBank基因库公布的HSV1-tk基因序列(gi：59974)完全一致。并与gag-pol表达质粒pGP和env表达质粒pE-ampho通过包装细胞制备成感染性假病毒颗粒。
经G418抗生素阳性筛选及有限稀释单克隆法培养出含HSV1-tk基因的单克隆细胞株,RT-PCR检测证实外源基因HSV1-tk成功导入A549细胞。
比较A549-tk细胞株和正常A549两者的生长及形态特征并绘制细胞生长曲线,结果发现两种细胞的外形基本一致,生长特征也无明显差别(P>0.05)。
A549-tk细胞株和A549细胞的成瘤率均为100%。比较了两种细胞肿瘤的生长特征,发现正常A549瘤和A549-tk两者之间的肿瘤的生长大小并无明显差异(P>0.05)。三次传代后经RT-PCR检测表明,成功建立了能稳定高效表达HSV1-tk基因的动物模型。
结论
1重组质粒pDON-AI-2-Neo-HSV1-tk能在肺腺癌细胞A549进行正确的翻译表达。
2外源基因HSV1-tk在成功制备的A549-tk细胞株中可被长期稳定表达。
3外源基因HSV1-tk的导入并没有影响到A549细胞的正常生理功能和形态。
4外源HSV1-tk报告基因导入A549细胞后对肿瘤的生长状况无明显影响。
5本实验成功建立了能稳定高效表达HSV1-tk基因的动物模型。
OBJECTIVE
The current incidence and mortality of lung cancer has grown rapidly, It has become one reason of the major human deaths, the most prominent of which is the Increase of lung adenocarcinoma. the overall effect of Chemotherapy and drug treatment is less optimistic. The cancer is prone to form local recurrence and distant metastasis,. Gene therapy for lung cancer is an important issue for treatment of lung cancer, in which suicide gene (suicidegene) therapy is considered the most promising method of gene therapy.
At present, herpes simplex virus (HSV1-tk) genetic research is the most of many therapeutic genes and the most promising of radioactive nuclides with catalytic "suicide gene". In addition, HSVl-tk has reporter gene features. Thus establishing the nude mice animal model of lung cancer of carrying tk gene, then expressing thymidine kinase TK in vivo, intaked in a amount of exogenous of radionuclides such as 18F, 124I,131I, etc. substrate nucleoside analogues labeled. We can monitor with real-time monitoring the expression of tk suicide gene in target cells by PET imaging which is basis for further in-depth study for the lung cancer suicide gene therapy research. Also, We can for the next double reporter gene imaging of double tracking and monitoring of bone marrow mesenchymal stem cells in vivo feasibility of laying foundation repair
CONTENT
The exogenous suicide gene is transduced into human tumor cells in different places and the stable、efficient expression successfully in target cells are the keys of gene therapy for cancer. In addition, the real-time detection of the distribution of suicide gene in vivo with patients and treatment status to the entire treatment process is an integral part. In this study, we transfect HSV1-tk suicide gene and reporter gene into lung adenocarcinoma A549 cells with retroviral vector-mediated,based on previous study.By screening positive transduced cells, re-use dilution to establish the monoclonal lung adenocarcinoma cell line A549-tk which can stable express HSV1-tk gene, Observion the difference of the morphology and growth status between the normal A549 cells and A549-tk cells,. Established lung cancer model of nude mice with carrying tk gene, testing whether the TK gene can express long-term stability in vivo
METHODS
HSV1-tk gene of fragment with restriction site of Bgl II, Sall is amplified by Molecular cloning. The retroviral vector pDON-AI-2-Neo which HSV1-tk gene is inserted into, and the plasmid pGP expressing gag-pol and the plasmid pE-ampho expressing env are transfected 293T packaging cells by liposome to form artificial recombinant virus particles carrying pDON-AI-2-Neo-HSV1-tk reporter gene. Then it is transfected A549 lung cancer cells.The transfected cells by G418 selecting positive expression, then with limiting dilution Monoclonal is formed stable expression strain.RT-PCR testing confirmed the expression of exogenous HSV1-tk gene in A549-tk cells is stability in the mRNA level. The morphology observation and cell growth curve are finished with the long passage of cell culture growth.. Cloned tumor cell lines are implanted into nude mice, studying the difference between the normal A549 and A549-tk tumor tumor growth, RT-PCR detects HSV1-tk gene expression of A549-tk tumor
RESULTS
The HSV1-tk gene of plasmid pDON-AI-2-Neo-HSVl-tk is consistent with HSV1-tk gene sequences (gi:59974) published by GenBank gene pool with digesting and sequencing.It is usd to merged the plasmid pGP expressing gag-pol and the plasmid pE-ampho expressing envl which were prepared false infectious particles by packaging cel
Positive selection by the antibiotic G418 and limiting dilution method cultivate a monoclonal cell lines expressing HSV1-tk gene, and RT-PCR confirmed HSV1-tk gene is transfected into A549 cells successfully
We found that the same shape of two cells are basically, and no significant difference in growth characteristics (P> 0.05) by compareing morphology and the cell growth curve between A549-tk cell line and normal A549 growth
A549-tk tumor growth was 100%, that is no different with A549 cells on tumorigenicity.We found that the tumor size and tumor growth between the normal A549 and A549-tk tumors was no significant difference (P> 0.05) by compareing the growth characteristics of two cell tumors. After three passages, RT-PCR analysis showed that the successful establishment of stable and efficient expression of HSV1-tk gene in an animal model
CONCLUTION
1 The plasmid pDON-AI-2-Neo-HSVl-tk can be translated and expressed correctly in adenocarcinoma of lung A549 cell.
2 HSV1-tk gene in A549-tk cells can be stability expressed after long-term successfully.
3 the exogenous gene HSV1-tk imported did not affect the normal physiological function and morphology of A549 cells.
4 After exogenous HSV1-tk reporter gene into A549 cells, there is no significant effect for the state on tumor growth.
5 The experiment is successfully established an animal mode expressing HSV1-tk gene stablely and efficiently.
现今肺癌的发病率和死亡率增长迅速,已成为人类死亡的主要原因之一,各细胞类型中以肺腺癌的增加尤为明显。临床发现多为中晚期,手术及放化疗的总体疗效不甚乐观,易出现局部复发及远处转移。基因治疗是目前肺癌治疗的研究热点之一,其中自杀基因(suicidegene)治疗被认为是最有应用前景的基因治疗方法。
目前,诸多治疗基因中单纯疱疹病毒胸苷激酶HSV1-tk基因研究最多,是最具前景的具有催化放射性核素的“自杀基因”。此外,HSV1-tk还兼具报告基因功能,故建立携带tk基因的肺腺癌裸鼠动物模型后,可在活体状态下能表达胸苷激酶ΓK。18F、124I、131I等标记的核苷类似物作为底物进行反应后通过PET显像实时监测HSV1-tk自杀基因在靶细胞内的表达情况,为今后进一步深入研究肺癌的自杀基因治疗研究和监测奠定基础。同时,也可以为下一步进行双报告基因报告显像跟踪监测骨髓间充质干细胞的活体修复等工作奠定可行性基础。
内容
将外源自杀基因特异地导入肿瘤细胞内并在靶细胞内高效且稳定的表达是能否成功基因治疗肿瘤的关键。对患者体内的自杀基因分布转导情况和治疗状态进行实时检测分析也是整个治疗过程中不可或缺的部分。故本研究拟在前期研究的基础上利用逆转录病毒载体介导HSV1-tk自杀基因兼报告基因转染肺腺癌A549细胞,经筛选阳性转导细胞,再利用稀释法单克隆建立一种能稳定表达HSV1-tk基因肺腺癌细胞株A549-tk,观察其与正常A549细胞的形态和生长状态的区别。建立能在活体内长期、稳定、高效表达HSV1-tk基因的肺腺癌裸鼠动物模型。
方法
利用分子克隆技术扩增带Bg1II、Sa1I酶切位点的HSV1-tk全基因片段,插入逆转录病毒载体pDON-AI-2-Neo中,与gag-pol表达质粒pGP和env表达质粒pE-ampho利用脂质体法转染293T包装细胞,形成pDON-AI-2-Neo-HSVI-tk重组报告基因假病毒颗粒,然后用其转染肺癌A549细胞,经G418筛选阳性表达,再经有限稀释法单克隆获得稳定表达株,RT-PCR检测证实A549-tk细胞的外源HSV1-tk基因在mRNA水平的稳定表达。通过长时间的传代培养进行细胞的生长、形态观察并绘制细胞生长曲线。将克隆细胞株种瘤于裸鼠后,比较正常A549瘤和A549-tk瘤两者之间的生长差异,取动物模型的成瘤做RT-PCR检测到HSV1-tk基因的表达.
结果
重组质粒pDON-AI-2-Neo-HSV1-tk经过酶切、测序鉴定证明与GenBank基因库公布的HSV1-tk基因序列(gi：59974)完全一致。并与gag-pol表达质粒pGP和env表达质粒pE-ampho通过包装细胞制备成感染性假病毒颗粒。
经G418抗生素阳性筛选及有限稀释单克隆法培养出含HSV1-tk基因的单克隆细胞株,RT-PCR检测证实外源基因HSV1-tk成功导入A549细胞。
比较A549-tk细胞株和正常A549两者的生长及形态特征并绘制细胞生长曲线,结果发现两种细胞的外形基本一致,生长特征也无明显差别(P>0.05)。
A549-tk细胞株和A549细胞的成瘤率均为100%。比较了两种细胞肿瘤的生长特征,发现正常A549瘤和A549-tk两者之间的肿瘤的生长大小并无明显差异(P>0.05)。三次传代后经RT-PCR检测表明,成功建立了能稳定高效表达HSV1-tk基因的动物模型。
结论
1重组质粒pDON-AI-2-Neo-HSV1-tk能在肺腺癌细胞A549进行正确的翻译表达。
2外源基因HSV1-tk在成功制备的A549-tk细胞株中可被长期稳定表达。
3外源基因HSV1-tk的导入并没有影响到A549细胞的正常生理功能和形态。
4外源HSV1-tk报告基因导入A549细胞后对肿瘤的生长状况无明显影响。
5本实验成功建立了能稳定高效表达HSV1-tk基因的动物模型。
OBJECTIVE
The current incidence and mortality of lung cancer has grown rapidly, It has become one reason of the major human deaths, the most prominent of which is the Increase of lung adenocarcinoma. the overall effect of Chemotherapy and drug treatment is less optimistic. The cancer is prone to form local recurrence and distant metastasis,. Gene therapy for lung cancer is an important issue for treatment of lung cancer, in which suicide gene (suicidegene) therapy is considered the most promising method of gene therapy.
At present, herpes simplex virus (HSV1-tk) genetic research is the most of many therapeutic genes and the most promising of radioactive nuclides with catalytic "suicide gene". In addition, HSVl-tk has reporter gene features. Thus establishing the nude mice animal model of lung cancer of carrying tk gene, then expressing thymidine kinase TK in vivo, intaked in a amount of exogenous of radionuclides such as 18F, 124I,131I, etc. substrate nucleoside analogues labeled. We can monitor with real-time monitoring the expression of tk suicide gene in target cells by PET imaging which is basis for further in-depth study for the lung cancer suicide gene therapy research. Also, We can for the next double reporter gene imaging of double tracking and monitoring of bone marrow mesenchymal stem cells in vivo feasibility of laying foundation repair
CONTENT
The exogenous suicide gene is transduced into human tumor cells in different places and the stable、efficient expression successfully in target cells are the keys of gene therapy for cancer. In addition, the real-time detection of the distribution of suicide gene in vivo with patients and treatment status to the entire treatment process is an integral part. In this study, we transfect HSV1-tk suicide gene and reporter gene into lung adenocarcinoma A549 cells with retroviral vector-mediated,based on previous study.By screening positive transduced cells, re-use dilution to establish the monoclonal lung adenocarcinoma cell line A549-tk which can stable express HSV1-tk gene, Observion the difference of the morphology and growth status between the normal A549 cells and A549-tk cells,. Established lung cancer model of nude mice with carrying tk gene, testing whether the TK gene can express long-term stability in vivo
METHODS
HSV1-tk gene of fragment with restriction site of Bgl II, Sall is amplified by Molecular cloning. The retroviral vector pDON-AI-2-Neo which HSV1-tk gene is inserted into, and the plasmid pGP expressing gag-pol and the plasmid pE-ampho expressing env are transfected 293T packaging cells by liposome to form artificial recombinant virus particles carrying pDON-AI-2-Neo-HSV1-tk reporter gene. Then it is transfected A549 lung cancer cells.The transfected cells by G418 selecting positive expression, then with limiting dilution Monoclonal is formed stable expression strain.RT-PCR testing confirmed the expression of exogenous HSV1-tk gene in A549-tk cells is stability in the mRNA level. The morphology observation and cell growth curve are finished with the long passage of cell culture growth.. Cloned tumor cell lines are implanted into nude mice, studying the difference between the normal A549 and A549-tk tumor tumor growth, RT-PCR detects HSV1-tk gene expression of A549-tk tumor
RESULTS
The HSV1-tk gene of plasmid pDON-AI-2-Neo-HSVl-tk is consistent with HSV1-tk gene sequences (gi:59974) published by GenBank gene pool with digesting and sequencing.It is usd to merged the plasmid pGP expressing gag-pol and the plasmid pE-ampho expressing envl which were prepared false infectious particles by packaging cel
Positive selection by the antibiotic G418 and limiting dilution method cultivate a monoclonal cell lines expressing HSV1-tk gene, and RT-PCR confirmed HSV1-tk gene is transfected into A549 cells successfully
We found that the same shape of two cells are basically, and no significant difference in growth characteristics (P> 0.05) by compareing morphology and the cell growth curve between A549-tk cell line and normal A549 growth
A549-tk tumor growth was 100%, that is no different with A549 cells on tumorigenicity.We found that the tumor size and tumor growth between the normal A549 and A549-tk tumors was no significant difference (P> 0.05) by compareing the growth characteristics of two cell tumors. After three passages, RT-PCR analysis showed that the successful establishment of stable and efficient expression of HSV1-tk gene in an animal model
CONCLUTION
1 The plasmid pDON-AI-2-Neo-HSVl-tk can be translated and expressed correctly in adenocarcinoma of lung A549 cell.
2 HSV1-tk gene in A549-tk cells can be stability expressed after long-term successfully.
3 the exogenous gene HSV1-tk imported did not affect the normal physiological function and morphology of A549 cells.
4 After exogenous HSV1-tk reporter gene into A549 cells, there is no significant effect for the state on tumor growth.
5 The experiment is successfully established an animal mode expressing HSV1-tk gene stablely and efficiently.
引文
[1].罗麟洁,徐丽娜,张洁,等.RNA (?)扰技术沉默STAT3对肺腺癌A549细胞生长抑制的作用[J].细胞与分子免疫学杂志,2010,26(7)：716-718
[2].FessdlaF, Pereim JR, von Pawel J, et al. Randomized, multinational, phaselll study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer:the TAX 326 study group. J Clin Oncol,2003,21:3016-3024
[3].周人杰，廖卫公，杨镇洲.ATRA对A549人肺腺癌细胞株增殖、细胞周期 的影响及其机制研究[J].第三军医大学学报，2007,29(14):1399-1400
[4].吴秋歌,蒋军广,王静P13K/Akt抑制剂对肺腺癌A549细胞增殖活性的影响[J].中国老年学杂志,2011,31(2)：278-279
[5].Tomm asi S, P into R, P ilato B, et al.Molecular pathways and related target therapies in liver carcinoma[J].Curr Pharm Des,2007,13 (32):3279-3287
[6]. Li YG, Wang ZP, Tian J Q, et al. Dendritic cell transfected with secondary lymphoid2tissue chemokine and/or interleukin-2 gene-enhanced cytotoxicity of T-lymphocyte in human bladder tumor cells in vitro [J]. Cancer Invest,2009,12:1
[7]. Kunze D, Wuttig D, Fuesscl S, et al. Multitarget siRNA inhibition of antiapoptotic genes (XIA P, BCL2, BCL-X(L)) in bladder cancer cells[J]. Anticancer Res,2008,28(4B):2259
[8]. Tang L, Hu HD, Hu P, et al. Gene therapy with CX3CL1/Fractalkine induces antitumor immunity to regress effectively mouse hepatocellular carcinoma [J]. Gene Ther,2007,14 (16):1226-1234
[9]. Zhang Z, Lin J, Chu J, et al. Activation of carpare-3 noninvolved in the bystander effect of the herpes simplex virus thymidine kinase gene ganciclovir(HSV-tk/GCV)system[J]. J Biomed Opt,2008,13(3):031209
[10]. Mitrovie'T, Radulovic'S. Gene therapy of cancer[J].J BUON,2005,10(2): 167-173
[11]. Moolten F.L Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes [J]. Cancer Res,1986,46:5276-5281
[12].高慧,杨耀琴,陶惠红,等.HSV-tk基因表达载体的构建及其对A549细胞的杀伤作用[J].同济大学学报(医学版),2009,30(5)：24-31
[13]. Faneca H, Faustino A, Pedroso de L ima MC. Synergistic antitumoral effect of vinblastine and HSV-Tk/GCV gene therapy mediated by albumin-associated cationic liposomes [J]. J Control Release,2008,126 (2):175-184.
[14].刘刚,欧阳德群,赵劲风,等HSV-TK自杀基因联合热疗杀伤肝癌细胞系的实验研究[J].中国普通外科杂志,2009,28(7)：713-716
[15].白志杰,黎玮,王亚轩,等.腺病毒介导的HSV-tk/GCV自杀基因系统靶向性治疗前列腺癌的实验研究[J].现代泌尿外科杂志,2009,14(6)：447-450
[16]. Jin P, Kong BH, Ai Zheng, et al. Inhibitory effect of polyethy lenimine-mediated transfection of suicide gcne HSV-tk with an ovarian-specific promoter on growth of ovarian cancer cell line SKOV3[J].Chinese Journal of Cancer,2005,24(7):806-811
[17].房娜,徐文贵,于津浦,等HSVl-tk基因逆转录病毒载体构建、病毒包装及稳定细胞株建立[J].中国老年学杂志,2007,27(6)：528-531
[18].Colombo F, Barzon L, Franchin E, et al. Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme:biological and clinical results[J].Cancer Gene The,2005,12(10):835-848
[19].徐文贵,杨昆,房娜,等.乳腺癌T47D-tk细胞生长特性及移植瘤动物模型的建立[J].中华医学杂志,2009,89(6)：423-426
[20].Deng W P, Yang W K, Lai W F, et al. Non-invasive in vivo imaging with radiolabelled FIAU for monitoring cancer gene therapy using herpes simplex virus type 1 thymidine kinase and ganciclovir[J].Eur J Nucl Med Mol Imaging,2004,31(l):99-109
[21].张斌青,吴涛,孙逊,等.腺病毒载体携带HSV1-TK报告基因感染BMSCs后摄取I-FIAU的实验研究[J].核技术,2010,33(4)：303-307
[22].王全师,李洪生,唐刚华,等18F-FHBG PET裸鼠移植瘤的HSVl-tk基因显像[J].核技术杂志,2009,32(5)：379-382
[23].J.萨姆布鲁克,DW.拉塞尔(黄培堂译).分子克隆实验指南[M]第3版.北京：科学出版社.2002：26-36
[24].Shimotohuo K, Temin H M. Formation of infectious progeny virus after insertion of herpes simplex thymidine kinase gene into DNA of an avian retrovirus [J].Cell,1981,26:67-77
[25].Jeanette Neumann, Jorn Stitz, Renate Konig, et al. Retroviral vectors for vaccine development:induction of HIV-1-specific humoral and cellular immune responses in rhesus macaques using a novel MLV(HIV-1) pseudo-otype vector[J].Journal of Biotechnoiogy,2006,124:615-625
[26].Veronique Roelants,Carole de Meester, Xavier Havaux, et al. Comparison between adenoviral and retroviral vectors for the transduction of the thymidine kinase PET reporter gene in rat mesenchymal stem cells[J].NUCLEAR MEDICINE,2008,49(11):1836-1844
[27].Makoto Yamagishi, Takaomi Ishida, Ariko Miyake. et al. Retroviral deliver of promoter-targeted shRNA induces long-terra silencing of HIV-1 transcription[J].Microbes and Infection,2009,11:500-508
[28]. Ram Z, Culver K.W, Walbrige S, et al. Insitu retroviral mediated gene transfer for the treatment of brain tumors in rats[J]. Cancer Res, 1993,53(1):83-88
[29].王毅,胡志前,徐学俊,等.逆转录病毒介导的HSV-TK系统对胃癌细胞的转染及杀伤作用[J].第二军医大学学报,2001,22(4)328-330
[30].张巨峰,陈艳娜,张文峰,等.人IL-12重组逆转录病毒载体在HeLa细胞中表达[J].现代生物医学展,2010,10(7)：1205-1206
[31].张惠中,范清宇,杨安钢.产生重组逆转录病毒包装细胞系建立及病毒滴度影响因素[J].第四军队大学学报,2001,22(4)：313-315
[32].杨生玺,蒋虹.重组逆转录病毒载体的包装及病毒滴度影响因素[J].第四军医大学学报,2005,26(14)：313-315
[33]. Cherry Ee Lin Ng, Yoshiaki Ito, Motomi Osato. Retroviral integration sites(RIS)mark cis-regulatory Elements[J]. Critical Reviews in On-cology/ Hematology,2009,71:1-11
[34]. R ainov N G, K ramm CM, Bann ing U, et al. Immune response induced by retroviru s-m ediated HSV-tk/GCV pharm acogene therapy in patien ts with gliob lastom a multiforme [J].Gene T her,2000,7 (21):1853-1858
[35].谢文练,黄健,韩金利,等.逆转录病毒介导HSV-TK基因结合更昔洛韦对裸鼠膀胱癌模型的抑癌作用[J].中华泌尿外科杂志,2005,26(11)：752-754
[36]. Toyokaw a Y, Ku riyam a S, T su jinoue H, et al. Retroviru s-mediated in vivo gene therapy using the herpes simplex virus thymidine kinase gene against carcinom atou speritonitis [J].Scand J Gastroen terol,2000,35 (8) 852-860
[37].Anderson WF. Gene therapy for cancer. Human Gene Therapy,1994,5:1
[38].Gerolam R, Cardoso J, Lewin M, et al. Evaluation of HSV-TK gene therapy in a rat model of chemically induced hepatocellular carcinoma by intratumoral and intrahepatic artery routes[J]. Cancer Res,2000,60:993
[39].吕英谦,毛泽斌,周艳艳,等.组织特异性启动子介导的反义FGF8b RNA对前列腺癌细胞生长增殖能力的影响[J].中国生物化学与分子生物学报,2002,18(6)：755-761
[40].Nasu Y, Saika T, Ebara S, et al. Suicide Gene Therapy With Aden oviral Delivery of HSV-tK Gene for Patients With Local Recurrence of Prostate Cancer After H ormonal T herapy[J].MolTher,2007,15(4):834-840
[41].Ryosuke Uchibori, Takashi Okada, Takayuki Ito, et al. Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy [J]. Gene Medicine,2009; 11:373-381
[42].Azatian A, Yu H, Dai W, et al. Effectiveness of HSV-tk suicide gene therapy driven by the Grp78 stress-inducible pomoter in esophagogastric junction and gastric adenocarcinomas[J]. J Gastrointest Surg.2009,13(6):1044-1051
[43].Vogl-Willis CA, Edwards IJ. High glucose-induced alterations in Subend-othelial matrix perlecna leads to increased monocyte binding[J].Arterioscler Thermb VascBiol,2004,24(5):858
[44].Pu, K,Li, S.y,Gao, Y, et al, Bystander effect in suicide gene therapy using immortalized neural stem cells transduced with herpes simplex virus thymidine kinase gene on medulloblastoma regression [J]. Brain Research, 2011,19(1369):245-52
[45].Andrade AF, S Kit, M Sheppard,etal. Nucleotide sequence of the thymidine kinase gene of herpes simplex virus typel [J].Brain Res,2000,32(1):308-312
[46].Tourine RL,Navahanian, Ramsey WJ, et al. Enhancement of the HSV-TK/GCV bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions [J].Hum Gene Ther,1998,9 (4):2234-2238
[47].Engelmnn, Jean-Marie,Monigue Fabre. et al. Herpes simplex virus thymidine kinase gene/ganciclovir-mediated apoptotic death of bystander cells[J].Cancer Letter,2002,15(56):2697-2702
[48].康保国,王卫东,陈正堂,等.放射诱导HSV-TK基因在肺癌细胞中靶向、高效性表达的研究[J].重庆医学,2007,36(6)：505-510
[49]. Inubushi M, Tamaki N. Radionuclide reporter gene imaging for cardiac gene therapy[J].Eur J Nucl Med Mol Imaging,2007,34(6):827-833
[50].刘影,兰晓莉,张永学.单纯疱疹病毒1-胸苷激酶报告基因显像研究进展[J].国际放射医学核医学杂志,2007,31(6)：329-336
[51].陈虞梅,黄钢.PET报告基因显像[J].国际放射医学核医学杂志,2006,30(3)：139-141
[52].Tadashi Miyagawa, George Gogiberidze, Inna Serganova, et al. Im aging of HSV-tk Reporter Gene Expressio:Comparison Between [18F]FEAU, [18F]FFEAU and Other Imaging Probes [J]. Nuclear Medicine,2008, 4(4):637-647
[53].Keon Wook Kang, Jung-Joon Min, Xiaoyuan Chen, et al. Comparison of [14C]FMAU, [3H]FEAU,[14C]FIAU, and [3H]PCV for Monitoring Reporter Gene Expression of Wild Type and MutantHerpes Simplex Virus Type 1 Thymidine Kinase in Cell Culture[J]. Molecular Imaging and Biology 2005 (7):296-303
[54]. Lan, Xiaoli; Liu, Ying; He, Yong, et al. Autoradiography study and SPECT imaging of reporter gene HSV1-tk expression in heart[J]. Nucl Med Biol 2010,37(3):371-80
[55].Yury Likar, Konstantin Dobrenkov,Malgorzata Olszewska et al. PET imaging of HSV1-tk mutants with acquired specificity toward pyrimidine and acyclo ‘guanosine-basedradiotracers[J].EurJNuclMedMolImaging 2009(36):1273-1282
[56].Wang H E, Yu H M, Liu R S, et al.Molecular Imaging with 123I-FIAU, 18F-FUdR,18F-FET, and 18F-FDG for Monitoring Herpes Simplex Virus Type 1 Thymidine Kinase and Ganciclovir Prodrug Activation Gene Therapy of Cancer[J].J Nucl Med,2006,47(7):1161-1171
[57].尹小花,兰晓莉,王瑞华,等.腺病毒载体介导的HSV1-tk报告基因感染心肌细胞后摄取125I-FIAU的实验研究[J].核技术杂志,2008,31(3)：854-858
[58].Amer M. Najjar, Ryuichi Nishii, David S, et al. Molecular-Genetic PET Imaging Using an HSV1-tk Mutant Reporter Gene with Enhanced Specificity to Acycloguanosine Nucleoside Analogs[J]. Nuclear Medicine,2009, 50:409-416
[59].薛丽香,童坦君,张宗玉,报告基因的选择及其研究趋向[J].生理科学进展,2002,33(4)：364-366
[60]. Colombo F, Barzon L, Franchin E, et al. Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme:biological and clinical results[J]. Cancer Gene Ther,2005,12 (10):835-848
[61].Jacobs A H, Winkeler A, Hartung M. et al. Improved herpes simplex virus type lamplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes[J].Hum Gene Ther,2003,14(3): 277-297
[62].徐文贵,戴东,房娜,等.HSV1-tk乳腺癌移植瘤裸鼠模型PET-CT报告基因显像[J].中华医学杂志,2009,89(48)：3420-3424
[63].Dotti G, Tian M, Savoldo B, et al. Repetitive noninvasive monitoring of HSV1-tk-expressing T cells intravenously infused into nonhuman primates using positron emission tomography and computed tomography with 18F-FEAU.[J].Molecular Imaging.2009 Jul-Aug;8(4):230-237
[64].Kang KW, Min JJ, Chert X, et al. Comparison of[14C]FMAU, [3H]FEAU, [14C]FIAU, and [3H]PCV for monitoring reporter gene expression of wild type and mutant herpes simplex virus type 1 thymidine kinase in cell culture[J].Mol Imaging Biol,2005,7(4):296-303
[65].Ji Yun Kim, Ji Hyun Kim, Maria Khim, et al. Persistent anti-tumor effects via recombinant adeno-associated virus encoding herpes thymidine kinase gene monitored by PET-imaging[J].Oncology Reports,2011,10 (3892):1263-1269
[66].You La Lee, Yong Jin Lee, Sohn Joo Ahn, et al. Combined radionuclide-chemotherapy and in vivo imaging of hepatocellular carcinoma cells after transfection of a triple-gene construct, NIS, HSV1-sr39tk, and EGFP[J].Cancer Lett,2010,290(1):129-38
[1].Ke Pu, Shao-yi Li, Yun Gao, et al, Bystander effect in suicide gene therapy using immortalized neural stem cells transduced with herpes simplex virus thymidine kinase gene on medulloblastoma regression [J]. Brain Research,2011,19(1369):245-52
[2].Vogl-Willis CA, Edwards IJ. High glucose-induced alterations in Subendothelial matrix perlecna leads to increased monocyte binding[J]. Arterioscler Thermb VascBiol,2004,24(5):858
[3].Nagy H, Panis Y, Fabre M,et al. Surgery,1998:123 (1):19-24
[4].Klamnann D, Valerry CA,Bensimen GT, etal.A phase I/Ⅱ dose-es-calation study of herpes simplex virus type 1 thymidine kinase suicide gene therapy for metastatic melanoma.Smdy Group on Gene Therapy of Metastatic Melanoma[J].Hum Gene.Ther,1998,9(17):2592-2604
[5].Azatian A, Yu H, Dai W, et al. Effectiveness of HSV-tk suicide gene therapy driven by the Grp78 stress-inducible promoter in esophagogastric junction and gastric adenocarcinomas[J]. J Gastrointest Surg.2009,13(6):1044-1051
[6]. Faneca H, Faustino A, Pedroso de L ima MC. Synergistic antitumoral effect of vinblastine and HSV-Tk/GCV gene therapy mediated by albumin-associated cationic liposomes [J]. J Control Release,2008,126 (2):175-184.
[7].Jin P, Kong BH, Ai Zheng, et al. Inhibitory effect of polyethylenimine-medi-ated transfection of suicide gene HSV-tk with an ovarian-specific promoter on growth of ovarian cancer cell line SKOV3[J]. Chinese Journal of Cancer,2005,24(7):806-811.
[8].Puumalainen AM, Vapalahti M, Agrawal RS,et al.Beta-galactosi-dase gene transfer to human malignant glioma in vivo using replication deficient retroviruses and adenoviruses[J]. Hum.CeneTher.1998,9:1769-1774
[9].滕颖,李秋香.肿瘤治疗中的自杀基因疗法[J].天津医药,2005,33(9)：614-616
[10].Misra V, Klamut HJ, Rauth AM. Ex pression of the prodrug activating enzyme DT diaphoraseviaAd5 delivery to Human colon carcinoma cells in vitro[J]. Cancer GeneTher,2002,9 (2):209.
[11].潘雪,李兆申,许国铭,等.CD/5-FC自杀基因系统治疗胰腺癌的实验研究[J].解放军医学杂志,2002,27(10)：878-882
[12].Kufe DW, Advani S, Weichselbaum R. Cancer gene therapy.In:Holland JF.Frei EⅢ,Bast RCJr,etal.CancerMedicine[M].5thed.Canada:B.C.Decker.Inc, 2000.876-889
[13].Bilsland AE et al.Oncogene[M].2003,22(3):370-380
[14].KrohneTU, Shankara S. Gelssler M, et al. Mechanisms of cell death induced by suicide encoding purine mucleoside phosphorylase and thymidine kinase in human hepatoclluar carcinoma cell in vitro[J].Hepatology,2001,34(3):511-518
[15].Cortes ML, GarciaEscudero V, Hughes M, et al. Cyanide bystander effect of the linamarase/linamarin killer suicide gene therapy system[J]. JGene Med, 2002,4(4):407-414
[16].Corban Wilhelm H, Becker G, Bauder Wust U, et al. Cytosine deaminase versus thymidine kinase:a comparison of the amtitumor activity[J].Clin Exp Med.2003.3(3):150-157
[17].Xia K, Liang DS, Tang A, et al. A novel fusion suicide gene yeast CdglyTK piaus a role in radio-gene therapy of nasopharyngeal carinoma[J].Cancer Gene Therapy,2004,11(12):790-797
[18].Zhang N, Zhang DS, Han JQ, et al. Radiosensitization by double suicide gene system in ACC-2 cell, Shanghai kou qiang yi xue[J].2009,18(2):183-188
[19].陈平,孙振华.自杀基因治疗肿瘤的现状与展望.实用临床医药杂志.2006,10(4)：128-131
[20].张未,潘仕荣,张璇,等.聚乙二醇一壳聚糖聚物作为基因传递载体的体外研究[J].药学学报,2008,43(8)：848—854
[21]. NakamuraT, Sato K, Hamada H. Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors[J]. Hum Gene Ther,2002,13:613-626
[22].Kruse CA, Lamb C, Hogan S, et al. Purified herpes simplex thvmidine kinase retroviral particlesll Influence of clinical parameters and bystander killing mechanisms[J].CatlcerGerieTher2000,7:118-127
[23].Puhlmann M, Brown CK, Gnant M, et al. Vaccinia as a vector for tumor directed gene therapy:biodistribution of a thvmidine kinase-deleted mutant[J]. Cancer Gene Ther,2000,7:66-73
[24].Mangeot PE, Negre D, Dubois B. et al. Development, of minimal lentivirus vectors derived from simian immunodeficiencyvirus (SIVmac251) and their use for gene transfer into human dendritic cells[J].J Virof 2000,74:8307-8315
[25].Cui Y, Golob j, Kelleher E, et al. Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engr afring human hematopoieticstem/Progenitor cells[J].Blood,2002;99:399-408
[26].罗勇,张阳德,彭健等.纳米磁流体介导的重组pEGFP-AFP-TK对AFP表达阳性肝癌细胞HepG2的杀伤作用的体外实验[J].细胞与分子免疫学杂志,2009,25(5)：437-442
[27].Corsi K, Chellat F, Yahia L, et al.Mesenchymal stem cells.MG63 and HEK293 transfection using chitosan-DNA nanoparticles[J].Biomat-erials, 2003,24(7):1255-1264
[28].Yang C, Lj H, Goh SH, et al. Cationic star polymers consisting of Alpha-cyclodextrin core and oligoethylenimine arms as nonviral gene delivery vectors[J].Biomaterials,2007,28(21):3245-3254.
[29].Zhao Liang, Su Chang, Ma Hong-lin. Theoretical research of cationic polymers as non-viral gene vectors[J].Journal of Clinical Rehabilitative Tissue Engineering Research,2009,13(24):8329-8332
[30].Makoto Yamagishi, Takaomi Ishida, Ariko Miyake, et al. Retroviral deliver of promoter-targeted shRNA induces long-terra silencing of HIV-1 transcription[J].Microbes and Infection,2009,11:500-508.
[31].Zhang Z, Shirakawa T, Hinta N, et al. Combination with CD/5Fc gene therapy enhance skill in gofhuman bladder cancer cells by radiation [J].JGeneMed,2003,5:860.
[32].Koboyashi N, Noguchi H, Totsugawa T, et al. Insertion of a suicide gene into animmortalized human hepatocyte cell line[J].Cell Transplant,2001,19(4-5): 373-376.
[33].徐文贵,杨昆,房娜,等.乳腺癌T47D-tk细胞生长特性及移植瘤动物模型的建立[J].中华医学杂志,2009,89(6)：423-426.
[34].苏丹.综述：自杀基因在肝癌治疗中的应用现状.中国肿瘤生物治疗杂志,2003,10(2)：146-148
[35].Tadashi Miyagawa. George Gogiberidze, Inna Serganova, etal. Imaging of HSV-tk Reporter Gene Expression:Comparison Between [18F]FEAU, [18F]FFEAU,and Other Imaging Probes[J]. THE JOURNAL OF NUCLEAR MEDICINE,2008,,4(4):637-647
[36]. Huang SY, Zhang DS, et al. Radiosensitization and Anti-tumour Effectsof Cytosine Deaminase and Thymidine Kinase Fusion Suicide Gene in Human Adenoid Cystic Carcinoma Cells[J]. The Journal of international medical research,2009,37(2):479-90
[37]. Guilhon E, Quesson B, Moraud Gaudry F, et al. Image-guided control of transgene expression based on local hyperthermia[J]. Mol Imagingm,2003,2(1):11-17
[38]. Shen J, Zhang W, W u J, et al. The synergistic reversal effect of multidrug resistance by quercetin:and hypertherm ia in doxorubicin-resistant human myelogenous leukem ia cells [J].Int J Hyperthermia,2008,24 (2):151-159.
[39].朱欠元,周玉梅,李宝金,等.HSV2TK.基因和IL 212基因治疗裸鼠鼻咽癌的实验研究[J].第四军医大学学报,2009,30(16)；1461-1463
[40]. Kojima Y, Honda K, Hamada H, et al.Oncolytic Gene Therapy Combined with Double Suicide Genes for Human Bile Duct Cancer in Nude Mouse Models[J]. The Journal of surgical research,2009,157(1):63-70
[41]. Tsuchiyama T,Kaneko S,Nakamoto Y, et al. Enhanced antitumor effects of a bicistronic adenovirus vector expressing both herpes simplex virus thymidine kinase and monocyte chemoattractant protein-1 against hepatocellular carcinoma[J].Cancer Gene Ther,2003,10(4):260-270
[2].FessdlaF, Pereim JR, von Pawel J, et al. Randomized, multinational, phaselll study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer:the TAX 326 study group. J Clin Oncol,2003,21:3016-3024
[3].周人杰，廖卫公，杨镇洲.ATRA对A549人肺腺癌细胞株增殖、细胞周期 的影响及其机制研究[J].第三军医大学学报，2007,29(14):1399-1400
[4].吴秋歌,蒋军广,王静P13K/Akt抑制剂对肺腺癌A549细胞增殖活性的影响[J].中国老年学杂志,2011,31(2)：278-279
[5].Tomm asi S, P into R, P ilato B, et al.Molecular pathways and related target therapies in liver carcinoma[J].Curr Pharm Des,2007,13 (32):3279-3287
[6]. Li YG, Wang ZP, Tian J Q, et al. Dendritic cell transfected with secondary lymphoid2tissue chemokine and/or interleukin-2 gene-enhanced cytotoxicity of T-lymphocyte in human bladder tumor cells in vitro [J]. Cancer Invest,2009,12:1
[7]. Kunze D, Wuttig D, Fuesscl S, et al. Multitarget siRNA inhibition of antiapoptotic genes (XIA P, BCL2, BCL-X(L)) in bladder cancer cells[J]. Anticancer Res,2008,28(4B):2259
[8]. Tang L, Hu HD, Hu P, et al. Gene therapy with CX3CL1/Fractalkine induces antitumor immunity to regress effectively mouse hepatocellular carcinoma [J]. Gene Ther,2007,14 (16):1226-1234
[9]. Zhang Z, Lin J, Chu J, et al. Activation of carpare-3 noninvolved in the bystander effect of the herpes simplex virus thymidine kinase gene ganciclovir(HSV-tk/GCV)system[J]. J Biomed Opt,2008,13(3):031209
[10]. Mitrovie'T, Radulovic'S. Gene therapy of cancer[J].J BUON,2005,10(2): 167-173
[11]. Moolten F.L Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes [J]. Cancer Res,1986,46:5276-5281
[12].高慧,杨耀琴,陶惠红,等.HSV-tk基因表达载体的构建及其对A549细胞的杀伤作用[J].同济大学学报(医学版),2009,30(5)：24-31
[13]. Faneca H, Faustino A, Pedroso de L ima MC. Synergistic antitumoral effect of vinblastine and HSV-Tk/GCV gene therapy mediated by albumin-associated cationic liposomes [J]. J Control Release,2008,126 (2):175-184.
[14].刘刚,欧阳德群,赵劲风,等HSV-TK自杀基因联合热疗杀伤肝癌细胞系的实验研究[J].中国普通外科杂志,2009,28(7)：713-716
[15].白志杰,黎玮,王亚轩,等.腺病毒介导的HSV-tk/GCV自杀基因系统靶向性治疗前列腺癌的实验研究[J].现代泌尿外科杂志,2009,14(6)：447-450
[16]. Jin P, Kong BH, Ai Zheng, et al. Inhibitory effect of polyethy lenimine-mediated transfection of suicide gcne HSV-tk with an ovarian-specific promoter on growth of ovarian cancer cell line SKOV3[J].Chinese Journal of Cancer,2005,24(7):806-811
[17].房娜,徐文贵,于津浦,等HSVl-tk基因逆转录病毒载体构建、病毒包装及稳定细胞株建立[J].中国老年学杂志,2007,27(6)：528-531
[18].Colombo F, Barzon L, Franchin E, et al. Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme:biological and clinical results[J].Cancer Gene The,2005,12(10):835-848
[19].徐文贵,杨昆,房娜,等.乳腺癌T47D-tk细胞生长特性及移植瘤动物模型的建立[J].中华医学杂志,2009,89(6)：423-426
[20].Deng W P, Yang W K, Lai W F, et al. Non-invasive in vivo imaging with radiolabelled FIAU for monitoring cancer gene therapy using herpes simplex virus type 1 thymidine kinase and ganciclovir[J].Eur J Nucl Med Mol Imaging,2004,31(l):99-109
[21].张斌青,吴涛,孙逊,等.腺病毒载体携带HSV1-TK报告基因感染BMSCs后摄取I-FIAU的实验研究[J].核技术,2010,33(4)：303-307
[22].王全师,李洪生,唐刚华,等18F-FHBG PET裸鼠移植瘤的HSVl-tk基因显像[J].核技术杂志,2009,32(5)：379-382
[23].J.萨姆布鲁克,DW.拉塞尔(黄培堂译).分子克隆实验指南[M]第3版.北京：科学出版社.2002：26-36
[24].Shimotohuo K, Temin H M. Formation of infectious progeny virus after insertion of herpes simplex thymidine kinase gene into DNA of an avian retrovirus [J].Cell,1981,26:67-77
[25].Jeanette Neumann, Jorn Stitz, Renate Konig, et al. Retroviral vectors for vaccine development:induction of HIV-1-specific humoral and cellular immune responses in rhesus macaques using a novel MLV(HIV-1) pseudo-otype vector[J].Journal of Biotechnoiogy,2006,124:615-625
[26].Veronique Roelants,Carole de Meester, Xavier Havaux, et al. Comparison between adenoviral and retroviral vectors for the transduction of the thymidine kinase PET reporter gene in rat mesenchymal stem cells[J].NUCLEAR MEDICINE,2008,49(11):1836-1844
[27].Makoto Yamagishi, Takaomi Ishida, Ariko Miyake. et al. Retroviral deliver of promoter-targeted shRNA induces long-terra silencing of HIV-1 transcription[J].Microbes and Infection,2009,11:500-508
[28]. Ram Z, Culver K.W, Walbrige S, et al. Insitu retroviral mediated gene transfer for the treatment of brain tumors in rats[J]. Cancer Res, 1993,53(1):83-88
[29].王毅,胡志前,徐学俊,等.逆转录病毒介导的HSV-TK系统对胃癌细胞的转染及杀伤作用[J].第二军医大学学报,2001,22(4)328-330
[30].张巨峰,陈艳娜,张文峰,等.人IL-12重组逆转录病毒载体在HeLa细胞中表达[J].现代生物医学展,2010,10(7)：1205-1206
[31].张惠中,范清宇,杨安钢.产生重组逆转录病毒包装细胞系建立及病毒滴度影响因素[J].第四军队大学学报,2001,22(4)：313-315
[32].杨生玺,蒋虹.重组逆转录病毒载体的包装及病毒滴度影响因素[J].第四军医大学学报,2005,26(14)：313-315
[33]. Cherry Ee Lin Ng, Yoshiaki Ito, Motomi Osato. Retroviral integration sites(RIS)mark cis-regulatory Elements[J]. Critical Reviews in On-cology/ Hematology,2009,71:1-11
[34]. R ainov N G, K ramm CM, Bann ing U, et al. Immune response induced by retroviru s-m ediated HSV-tk/GCV pharm acogene therapy in patien ts with gliob lastom a multiforme [J].Gene T her,2000,7 (21):1853-1858
[35].谢文练,黄健,韩金利,等.逆转录病毒介导HSV-TK基因结合更昔洛韦对裸鼠膀胱癌模型的抑癌作用[J].中华泌尿外科杂志,2005,26(11)：752-754
[36]. Toyokaw a Y, Ku riyam a S, T su jinoue H, et al. Retroviru s-mediated in vivo gene therapy using the herpes simplex virus thymidine kinase gene against carcinom atou speritonitis [J].Scand J Gastroen terol,2000,35 (8) 852-860
[37].Anderson WF. Gene therapy for cancer. Human Gene Therapy,1994,5:1
[38].Gerolam R, Cardoso J, Lewin M, et al. Evaluation of HSV-TK gene therapy in a rat model of chemically induced hepatocellular carcinoma by intratumoral and intrahepatic artery routes[J]. Cancer Res,2000,60:993
[39].吕英谦,毛泽斌,周艳艳,等.组织特异性启动子介导的反义FGF8b RNA对前列腺癌细胞生长增殖能力的影响[J].中国生物化学与分子生物学报,2002,18(6)：755-761
[40].Nasu Y, Saika T, Ebara S, et al. Suicide Gene Therapy With Aden oviral Delivery of HSV-tK Gene for Patients With Local Recurrence of Prostate Cancer After H ormonal T herapy[J].MolTher,2007,15(4):834-840
[41].Ryosuke Uchibori, Takashi Okada, Takayuki Ito, et al. Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy [J]. Gene Medicine,2009; 11:373-381
[42].Azatian A, Yu H, Dai W, et al. Effectiveness of HSV-tk suicide gene therapy driven by the Grp78 stress-inducible pomoter in esophagogastric junction and gastric adenocarcinomas[J]. J Gastrointest Surg.2009,13(6):1044-1051
[43].Vogl-Willis CA, Edwards IJ. High glucose-induced alterations in Subend-othelial matrix perlecna leads to increased monocyte binding[J].Arterioscler Thermb VascBiol,2004,24(5):858
[44].Pu, K,Li, S.y,Gao, Y, et al, Bystander effect in suicide gene therapy using immortalized neural stem cells transduced with herpes simplex virus thymidine kinase gene on medulloblastoma regression [J]. Brain Research, 2011,19(1369):245-52
[45].Andrade AF, S Kit, M Sheppard,etal. Nucleotide sequence of the thymidine kinase gene of herpes simplex virus typel [J].Brain Res,2000,32(1):308-312
[46].Tourine RL,Navahanian, Ramsey WJ, et al. Enhancement of the HSV-TK/GCV bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions [J].Hum Gene Ther,1998,9 (4):2234-2238
[47].Engelmnn, Jean-Marie,Monigue Fabre. et al. Herpes simplex virus thymidine kinase gene/ganciclovir-mediated apoptotic death of bystander cells[J].Cancer Letter,2002,15(56):2697-2702
[48].康保国,王卫东,陈正堂,等.放射诱导HSV-TK基因在肺癌细胞中靶向、高效性表达的研究[J].重庆医学,2007,36(6)：505-510
[49]. Inubushi M, Tamaki N. Radionuclide reporter gene imaging for cardiac gene therapy[J].Eur J Nucl Med Mol Imaging,2007,34(6):827-833
[50].刘影,兰晓莉,张永学.单纯疱疹病毒1-胸苷激酶报告基因显像研究进展[J].国际放射医学核医学杂志,2007,31(6)：329-336
[51].陈虞梅,黄钢.PET报告基因显像[J].国际放射医学核医学杂志,2006,30(3)：139-141
[52].Tadashi Miyagawa, George Gogiberidze, Inna Serganova, et al. Im aging of HSV-tk Reporter Gene Expressio:Comparison Between [18F]FEAU, [18F]FFEAU and Other Imaging Probes [J]. Nuclear Medicine,2008, 4(4):637-647
[53].Keon Wook Kang, Jung-Joon Min, Xiaoyuan Chen, et al. Comparison of [14C]FMAU, [3H]FEAU,[14C]FIAU, and [3H]PCV for Monitoring Reporter Gene Expression of Wild Type and MutantHerpes Simplex Virus Type 1 Thymidine Kinase in Cell Culture[J]. Molecular Imaging and Biology 2005 (7):296-303
[54]. Lan, Xiaoli; Liu, Ying; He, Yong, et al. Autoradiography study and SPECT imaging of reporter gene HSV1-tk expression in heart[J]. Nucl Med Biol 2010,37(3):371-80
[55].Yury Likar, Konstantin Dobrenkov,Malgorzata Olszewska et al. PET imaging of HSV1-tk mutants with acquired specificity toward pyrimidine and acyclo ‘guanosine-basedradiotracers[J].EurJNuclMedMolImaging 2009(36):1273-1282
[56].Wang H E, Yu H M, Liu R S, et al.Molecular Imaging with 123I-FIAU, 18F-FUdR,18F-FET, and 18F-FDG for Monitoring Herpes Simplex Virus Type 1 Thymidine Kinase and Ganciclovir Prodrug Activation Gene Therapy of Cancer[J].J Nucl Med,2006,47(7):1161-1171
[57].尹小花,兰晓莉,王瑞华,等.腺病毒载体介导的HSV1-tk报告基因感染心肌细胞后摄取125I-FIAU的实验研究[J].核技术杂志,2008,31(3)：854-858
[58].Amer M. Najjar, Ryuichi Nishii, David S, et al. Molecular-Genetic PET Imaging Using an HSV1-tk Mutant Reporter Gene with Enhanced Specificity to Acycloguanosine Nucleoside Analogs[J]. Nuclear Medicine,2009, 50:409-416
[59].薛丽香,童坦君,张宗玉,报告基因的选择及其研究趋向[J].生理科学进展,2002,33(4)：364-366
[60]. Colombo F, Barzon L, Franchin E, et al. Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme:biological and clinical results[J]. Cancer Gene Ther,2005,12 (10):835-848
[61].Jacobs A H, Winkeler A, Hartung M. et al. Improved herpes simplex virus type lamplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes[J].Hum Gene Ther,2003,14(3): 277-297
[62].徐文贵,戴东,房娜,等.HSV1-tk乳腺癌移植瘤裸鼠模型PET-CT报告基因显像[J].中华医学杂志,2009,89(48)：3420-3424
[63].Dotti G, Tian M, Savoldo B, et al. Repetitive noninvasive monitoring of HSV1-tk-expressing T cells intravenously infused into nonhuman primates using positron emission tomography and computed tomography with 18F-FEAU.[J].Molecular Imaging.2009 Jul-Aug;8(4):230-237
[64].Kang KW, Min JJ, Chert X, et al. Comparison of[14C]FMAU, [3H]FEAU, [14C]FIAU, and [3H]PCV for monitoring reporter gene expression of wild type and mutant herpes simplex virus type 1 thymidine kinase in cell culture[J].Mol Imaging Biol,2005,7(4):296-303
[65].Ji Yun Kim, Ji Hyun Kim, Maria Khim, et al. Persistent anti-tumor effects via recombinant adeno-associated virus encoding herpes thymidine kinase gene monitored by PET-imaging[J].Oncology Reports,2011,10 (3892):1263-1269
[66].You La Lee, Yong Jin Lee, Sohn Joo Ahn, et al. Combined radionuclide-chemotherapy and in vivo imaging of hepatocellular carcinoma cells after transfection of a triple-gene construct, NIS, HSV1-sr39tk, and EGFP[J].Cancer Lett,2010,290(1):129-38
[1].Ke Pu, Shao-yi Li, Yun Gao, et al, Bystander effect in suicide gene therapy using immortalized neural stem cells transduced with herpes simplex virus thymidine kinase gene on medulloblastoma regression [J]. Brain Research,2011,19(1369):245-52
[2].Vogl-Willis CA, Edwards IJ. High glucose-induced alterations in Subendothelial matrix perlecna leads to increased monocyte binding[J]. Arterioscler Thermb VascBiol,2004,24(5):858
[3].Nagy H, Panis Y, Fabre M,et al. Surgery,1998:123 (1):19-24
[4].Klamnann D, Valerry CA,Bensimen GT, etal.A phase I/Ⅱ dose-es-calation study of herpes simplex virus type 1 thymidine kinase suicide gene therapy for metastatic melanoma.Smdy Group on Gene Therapy of Metastatic Melanoma[J].Hum Gene.Ther,1998,9(17):2592-2604
[5].Azatian A, Yu H, Dai W, et al. Effectiveness of HSV-tk suicide gene therapy driven by the Grp78 stress-inducible promoter in esophagogastric junction and gastric adenocarcinomas[J]. J Gastrointest Surg.2009,13(6):1044-1051
[6]. Faneca H, Faustino A, Pedroso de L ima MC. Synergistic antitumoral effect of vinblastine and HSV-Tk/GCV gene therapy mediated by albumin-associated cationic liposomes [J]. J Control Release,2008,126 (2):175-184.
[7].Jin P, Kong BH, Ai Zheng, et al. Inhibitory effect of polyethylenimine-medi-ated transfection of suicide gene HSV-tk with an ovarian-specific promoter on growth of ovarian cancer cell line SKOV3[J]. Chinese Journal of Cancer,2005,24(7):806-811.
[8].Puumalainen AM, Vapalahti M, Agrawal RS,et al.Beta-galactosi-dase gene transfer to human malignant glioma in vivo using replication deficient retroviruses and adenoviruses[J]. Hum.CeneTher.1998,9:1769-1774
[9].滕颖,李秋香.肿瘤治疗中的自杀基因疗法[J].天津医药,2005,33(9)：614-616
[10].Misra V, Klamut HJ, Rauth AM. Ex pression of the prodrug activating enzyme DT diaphoraseviaAd5 delivery to Human colon carcinoma cells in vitro[J]. Cancer GeneTher,2002,9 (2):209.
[11].潘雪,李兆申,许国铭,等.CD/5-FC自杀基因系统治疗胰腺癌的实验研究[J].解放军医学杂志,2002,27(10)：878-882
[12].Kufe DW, Advani S, Weichselbaum R. Cancer gene therapy.In:Holland JF.Frei EⅢ,Bast RCJr,etal.CancerMedicine[M].5thed.Canada:B.C.Decker.Inc, 2000.876-889
[13].Bilsland AE et al.Oncogene[M].2003,22(3):370-380
[14].KrohneTU, Shankara S. Gelssler M, et al. Mechanisms of cell death induced by suicide encoding purine mucleoside phosphorylase and thymidine kinase in human hepatoclluar carcinoma cell in vitro[J].Hepatology,2001,34(3):511-518
[15].Cortes ML, GarciaEscudero V, Hughes M, et al. Cyanide bystander effect of the linamarase/linamarin killer suicide gene therapy system[J]. JGene Med, 2002,4(4):407-414
[16].Corban Wilhelm H, Becker G, Bauder Wust U, et al. Cytosine deaminase versus thymidine kinase:a comparison of the amtitumor activity[J].Clin Exp Med.2003.3(3):150-157
[17].Xia K, Liang DS, Tang A, et al. A novel fusion suicide gene yeast CdglyTK piaus a role in radio-gene therapy of nasopharyngeal carinoma[J].Cancer Gene Therapy,2004,11(12):790-797
[18].Zhang N, Zhang DS, Han JQ, et al. Radiosensitization by double suicide gene system in ACC-2 cell, Shanghai kou qiang yi xue[J].2009,18(2):183-188
[19].陈平,孙振华.自杀基因治疗肿瘤的现状与展望.实用临床医药杂志.2006,10(4)：128-131
[20].张未,潘仕荣,张璇,等.聚乙二醇一壳聚糖聚物作为基因传递载体的体外研究[J].药学学报,2008,43(8)：848—854
[21]. NakamuraT, Sato K, Hamada H. Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors[J]. Hum Gene Ther,2002,13:613-626
[22].Kruse CA, Lamb C, Hogan S, et al. Purified herpes simplex thvmidine kinase retroviral particlesll Influence of clinical parameters and bystander killing mechanisms[J].CatlcerGerieTher2000,7:118-127
[23].Puhlmann M, Brown CK, Gnant M, et al. Vaccinia as a vector for tumor directed gene therapy:biodistribution of a thvmidine kinase-deleted mutant[J]. Cancer Gene Ther,2000,7:66-73
[24].Mangeot PE, Negre D, Dubois B. et al. Development, of minimal lentivirus vectors derived from simian immunodeficiencyvirus (SIVmac251) and their use for gene transfer into human dendritic cells[J].J Virof 2000,74:8307-8315
[25].Cui Y, Golob j, Kelleher E, et al. Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engr afring human hematopoieticstem/Progenitor cells[J].Blood,2002;99:399-408
[26].罗勇,张阳德,彭健等.纳米磁流体介导的重组pEGFP-AFP-TK对AFP表达阳性肝癌细胞HepG2的杀伤作用的体外实验[J].细胞与分子免疫学杂志,2009,25(5)：437-442
[27].Corsi K, Chellat F, Yahia L, et al.Mesenchymal stem cells.MG63 and HEK293 transfection using chitosan-DNA nanoparticles[J].Biomat-erials, 2003,24(7):1255-1264
[28].Yang C, Lj H, Goh SH, et al. Cationic star polymers consisting of Alpha-cyclodextrin core and oligoethylenimine arms as nonviral gene delivery vectors[J].Biomaterials,2007,28(21):3245-3254.
[29].Zhao Liang, Su Chang, Ma Hong-lin. Theoretical research of cationic polymers as non-viral gene vectors[J].Journal of Clinical Rehabilitative Tissue Engineering Research,2009,13(24):8329-8332
[30].Makoto Yamagishi, Takaomi Ishida, Ariko Miyake, et al. Retroviral deliver of promoter-targeted shRNA induces long-terra silencing of HIV-1 transcription[J].Microbes and Infection,2009,11:500-508.
[31].Zhang Z, Shirakawa T, Hinta N, et al. Combination with CD/5Fc gene therapy enhance skill in gofhuman bladder cancer cells by radiation [J].JGeneMed,2003,5:860.
[32].Koboyashi N, Noguchi H, Totsugawa T, et al. Insertion of a suicide gene into animmortalized human hepatocyte cell line[J].Cell Transplant,2001,19(4-5): 373-376.
[33].徐文贵,杨昆,房娜,等.乳腺癌T47D-tk细胞生长特性及移植瘤动物模型的建立[J].中华医学杂志,2009,89(6)：423-426.
[34].苏丹.综述：自杀基因在肝癌治疗中的应用现状.中国肿瘤生物治疗杂志,2003,10(2)：146-148
[35].Tadashi Miyagawa. George Gogiberidze, Inna Serganova, etal. Imaging of HSV-tk Reporter Gene Expression:Comparison Between [18F]FEAU, [18F]FFEAU,and Other Imaging Probes[J]. THE JOURNAL OF NUCLEAR MEDICINE,2008,,4(4):637-647
[36]. Huang SY, Zhang DS, et al. Radiosensitization and Anti-tumour Effectsof Cytosine Deaminase and Thymidine Kinase Fusion Suicide Gene in Human Adenoid Cystic Carcinoma Cells[J]. The Journal of international medical research,2009,37(2):479-90
[37]. Guilhon E, Quesson B, Moraud Gaudry F, et al. Image-guided control of transgene expression based on local hyperthermia[J]. Mol Imagingm,2003,2(1):11-17
[38]. Shen J, Zhang W, W u J, et al. The synergistic reversal effect of multidrug resistance by quercetin:and hypertherm ia in doxorubicin-resistant human myelogenous leukem ia cells [J].Int J Hyperthermia,2008,24 (2):151-159.
[39].朱欠元,周玉梅,李宝金,等.HSV2TK.基因和IL 212基因治疗裸鼠鼻咽癌的实验研究[J].第四军医大学学报,2009,30(16)；1461-1463
[40]. Kojima Y, Honda K, Hamada H, et al.Oncolytic Gene Therapy Combined with Double Suicide Genes for Human Bile Duct Cancer in Nude Mouse Models[J]. The Journal of surgical research,2009,157(1):63-70
[41]. Tsuchiyama T,Kaneko S,Nakamoto Y, et al. Enhanced antitumor effects of a bicistronic adenovirus vector expressing both herpes simplex virus thymidine kinase and monocyte chemoattractant protein-1 against hepatocellular carcinoma[J].Cancer Gene Ther,2003,10(4):260-270